We are live on ! Find out more
WAY

Waystar Holding Corp

Positive
Neutral
Negative
Sentiment 3-Months
Positive 45%
Neutral 50%
Negative 5%

Positive
Zacks Investment Research
11 days ago
Strength Seen in Waystar (WAY): Can Its 9.5% Jump Turn into More Strength?
Waystar (WAY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Strength Seen in Waystar (WAY): Can Its 9.5% Jump Turn into More Strength?
Neutral
PRNewsWire
13 days ago
Waystar to Host Investor Day at Waystar True North™ Conference on August 25, 2026
LEHI, Utah and LOUISVILLE, Ky., July 1, 2026 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that it will host an Investor Day on Tuesday, August 25, 2026, in San Antonio, Texas, from 1:00 p.m.
Waystar to Host Investor Day at Waystar True North™ Conference on August 25, 2026
Positive
Seeking Alpha
26 days ago
Waystar: Silently Taking Over Healthcare Billing
Waystar Holding Corp. is rated buy, with an 85% upside to a $37 price target, as current share price reflects temporary private equity (PE) selling pressure, not business fundamentals. Waystar's revenue grew 22% YoY, profit margins remain above 40%, and a $200M buyback offsets PE overhang; 23 of 24 analysts rate it Buy/Strong Buy. The Iodine acquisition and AI-powered AltitudeAI suite expand WAY's end-to-end billing solutions, driving new client wins and high retention in a $100B+ addressable market.
Waystar: Silently Taking Over Healthcare Billing
Neutral
PRNewsWire
1 month ago
New Research Reveals Healthcare Leaders Who Unite Financial and Clinical Data Recover Millions in Previously Missed Revenue
Healthcare leaders show unanimous interest in a single AI-powered platform connecting the mid-cycle to the final claim — yet 86% are still leaving revenue on the table LEHI, Utah and LOUISVILLE, Ky., June 9, 2026 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today released The State of the Mid-Revenue Cycle report.
New Research Reveals Healthcare Leaders Who Unite Financial and Clinical Data Recover Millions in Previously Missed Revenue
Negative
Seeking Alpha
1 month ago
Baron Discovery Fund Q1 2026: Who Moved The Needle
In the first quarter of 2026, Baron Discovery Fund declined 10.65% (Institutional Shares), trailing the Russell 2000 Growth Index by 7.84% due to significant underperformance in the software sector. Advanced Energy Industries, Inc.'s stock rose during the quarter as the market began to appreciate the strength that the company would see in both its data center and semiconductor end markets. Baron Discovery Fund sold its investment in Intapp, Inc. in the quarter as the team believes that its other software holdings have better overall competitive advantages.
Baron Discovery Fund Q1 2026: Who Moved The Needle
Positive
Zacks Investment Research
1 month ago
TBRG vs. Waystar: Which Healthcare RCM Stock Is the Better Bet Now?
WAY's AI-driven RCM growth and strong Q1 results stand out, while TruBridge trades near its pending buyout price with limited upside.
TBRG vs. Waystar: Which Healthcare RCM Stock Is the Better Bet Now?
Neutral
PRNewsWire
1 month ago
Waystar to Speak at William Blair Conference
LEHI, Utah and LOUISVILLE, Ky., May 20, 2026 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that Chief Executive Officer Matt Hawkins will speak at the 46th Annual William Blair Growth Stock Conference on Tuesday, June 2, 2026, at 10:40 a.m.
Waystar to Speak at William Blair Conference
Positive
24/7 Wall Street
1 month ago
AI Is Coming for Pharmacy Benefit Managers: Potential Winners and Losers
Pharmacy benefit managers (PBMs) sit at the chokepoint of U.S. drug distribution.
AI Is Coming for Pharmacy Benefit Managers: Potential Winners and Losers
Neutral
PRNewsWire
1 month ago
Waystar Announces $200 Million Share Repurchase Authorization, Reflecting Confidence in Long-Term Outlook
LEHI, Utah and LOUISVILLE, Ky., May 19, 2026 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that its Board of Directors authorized a stock repurchase plan for up to $200 million of the Company's common stock.
Waystar Announces $200 Million Share Repurchase Authorization, Reflecting Confidence in Long-Term Outlook
Neutral
Seeking Alpha
2 months ago
Waystar: Revised Guidance Does Not Imply Demand Weakness
Waystar remains a buy as Q1 results confirm robust demand, with provider solutions leading and AI integration strengthening the platform story. WAY's Q1 revenue grew 22% y/y to $313.9M, with subscription revenue up 38% and net revenue retention at 111%, highlighting strong customer engagement. Patient payment solution headwinds stem from a faster shift to digital, seen as a near-term timing issue rather than a structural demand problem.
Waystar: Revised Guidance Does Not Imply Demand Weakness